North America Anticoagulant Reversal Drug Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Anticoagulant Reversal Drug Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Anticoagulant Reversal Drug Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Anticoagulant Reversal Drug Market Regional Analysis

6.2 North America Anticoagulant Reversal Drug Market Revenue 2017-2027 (US$ Million)

6.3 North America Anticoagulant Reversal Drug Market Forecast Analysis

7. North America Anticoagulant Reversal Drug Market Analysis – by Product

7.1 Prothrombin Complex Concentrates

7.1.1 Overview
7.1.2 Prothrombin Complex Concentrates: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Vitamin K

7.2.1 Overview
7.2.2 Vitamin K: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Protamine

7.3.1 Overview
7.3.2 Protamine: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Tranexamic Acid

7.4.1 Overview
7.4.2 Tranexamic Acid: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.5 Idarucizumab

7.5.1 Overview
7.5.2 Idarucizumab: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.6 AndeXXa

7.6.1 Overview
7.6.2 AndeXXa: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Anticoagulant Reversal Drug Market Analysis – by End User

8.1 Hospital Pharmacies

8.1.1 Overview
8.1.2 Hospital Pharmacies: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Retail Pharmacies

8.2.1 Overview
8.2.2 Retail Pharmacies: North America Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Anticoagulant Reversal Drug Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Anticoagulant Reversal Drug Market Breakdown, by Key Country, 2020 and 2027 (%)
9.2.1.1 North America Anticoagulant Reversal Drug Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.1.1 US: North America Anticoagulant Reversal Drug Market Breakdown, by Product
9.2.1.1.2 US: North America Anticoagulant Reversal Drug Market Breakdown, by End User

9.2.1.2 Canada: North America Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.2.1 Canada: North America Anticoagulant Reversal Drug Market Breakdown, by Product
9.2.1.2.2 Canada: North America Anticoagulant Reversal Drug Market Breakdown, by End User

9.2.1.3 Mexico : North America Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)

9.2.1.3.1 Mexico : North America Anticoagulant Reversal Drug Market Breakdown, by Product
9.2.1.3.2 Mexico : North America Anticoagulant Reversal Drug Market Breakdown, by End User

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Boehringer Ingelheim International GmbH

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Pfizer Inc

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Octapharma AG

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 AMAG PHARMACEUTICALS, INC.

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Fresenius Kabi AG

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 CSL Limited

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Grifols, S.A.

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Anticoagulant Reversal Drug Market

Analysis By Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa); End User (Hospital Pharmacies, Retail Pharmacies, and Others)